Calix Limited (ASX: CXL) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Calix Limited Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Calix Limited (ASX: CXL)
Latest News
Broker Notes
'Compelling' decarbonisation ASX share to buy for dirt cheap right now
Energy Shares
'Key pick': 2 ASX energy shares that you need to jump on now
Broker Notes
Top brokers name 3 ASX shares to buy today
Materials Shares
Pilbara Minerals share price higher on 'game changer' project with Calix
Share Gainers
Why Calix, Chalice Mining, Qantas, and Whitehaven Coal shares are rising
Investing Strategies
3 'bullish' ASX shares to buy as FOMO grips the market: expert
52-Week Lows
Why is the Calix share price stooping to a new 12-month low on Monday?
Share Fallers
Why Brainchip, Calix, Fortescue, and ResMed shares are sinking
Materials Shares
Why did this ASX All Ordinaries share crash 18% today?
Share Gainers
3 ASX 300 shares off to the races on Wednesday
Materials Shares
Why is the Calix share price frozen on Wednesday? (Hint: it involves Pilbara Minerals)
Earnings Results
3 ASX 300 shares that climbed higher on earnings updates today
Frequently Asked Questions
-
Calix Ltd does not pay shareholder dividends at this time.
-
Calix listed on the ASX on 20 July 2018.
CXL ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Calix Limited
Calix Ltd (ASX: CXL) is an Australian technology company. It has developed a patented, platform technology that essentially involves grinding minerals to between one-hundredth and one-thousandth of a millimetre in size, and then "flash" heating them in a reactor. As trapped gases in the minerals are released, they create highly porous honeycomb-like structures with similar properties to nanomaterials, but without the associated safety issues and costs. Calix's technology also allows for the separation of carbon dioxide, making it attractive to industries and companies looking to reduce carbon emissions.
Calix's technology is being used globally across many industries and sectors. These include advanced battery development, water and wastewater treatment, sustainable food, and biotechnology. The company has operations in Australia, New Zealand, Asia, Europe, and the United States.
Director Transactions Data provided by Morningstar.
| Date | Director | Type | Amount | Value | Notes |
|---|---|---|---|---|---|
| 05 Dec 2025 | Catriona Deans | Issued | 179,167 | $107,500 |
Director remuneration.
|
| 05 Dec 2025 | Helen Fisher | Issued | 112,500 | $67,500 |
Director remuneration.
|
| 05 Dec 2025 | Sarah Ryan | Issued | 112,500 | $67,500 |
Director remuneration.
|
| 05 Dec 2025 | Peter Dixon | Issued | 112,500 | $67,500 |
Director remuneration.
|
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Ms Catriona Alison Deans | Non-Executive DirectorNon-Executive Chairman | Mar 2023 |
Ms Deans is also a member of the Investment Committee at Main Sequence Ventures (CSIRO's innovation fund) and a Member of the AICD Corporate Governance Committee. Alison's previous directorships include Westpac Banking Corporation, Insurance Australia Group Limited and Social Ventures Australia. In her executive career, Alison was previously the CEO of eBay Australia and New Zealand, CEO of eCorp Limited (a publicly listed portfolio of digital businesses), CEO of Hoyts Cinemas, CEO of netus Pty Ltd (a technology investment company acquired by Fairfax), and a consultant with McKinsey & Company. She is member of Risk Management Committee and the Sustainability Committee.
|
| Ms Helen E Fisher | Non-Executive Director | Sep 2020 |
Ms Fisher is Managing Director and CEO of Bio Capital Impact Fund (BCIF). Prior to establishing BCIF, Helen was a partner of Deloitte for over 10 years and led Deloitte's Life Sciences industry practice in Australia for five years, having had many years of experience in the Life Sciences and Health Care industry. She also specialized in Financial Services, servicing some of the Australian banks and funds and has been involved in setting up several international funds, as well as advised on several M&A deals. Helen provided strategic advice to publicly listed multinational companies and has experience with capital raisings, licensing deals, demergers, implementing offshore expansions. She is Chair of the Risk Management Committee and member of the Sustainability Committee.
|
| Dr Philip (Phil) Hargraves Hodgson | Chief Executive OfficerManaging Director | Feb 2014 |
Dr Hodgson has a technical and commercial background from a career with Shell, where for over 14 years he developed depth of experience across all sectors of the downstream oil industry, including refining and supply, marketing and sales, pricing strategy, risk management, corporate strategy, and mergers and acquisitions. From 2007 to 2013, Phil ran his own consultancy, providing project development, commercial, M&A, and management expertise to several sectors, including LNG, biofuel, clean coal, geothermal energy, building products, logistics and fast-moving consumer goods. He is also member of Technology Committee.
|
| Dr Sarah Elizabeth Ryan | Non-Executive Director | Jan 2024 |
Dr Ryan brings global engineering and commercial experience, encompassing private equity, investment management, energy sector operations, marketing, research, and team management. With a particular emphasis on innovation and technology enabled solutions. Dr Ryan is also a Strategic Advisory Panel Member of the ARC Centre of Excellence for Green Electrochemical Transformation of Carbon Dioxide and Chair of the Energy Forum for the Australian Academy of Technological Sciences and Engineering.
|
| Mr Peter Matthew Francis Dixon | Non-Executive Director | Jan 2024 |
Mr Dixon has 25 years of experience across the legal, investment banking and funds management sectors, Mr Dixon brings expertise across corporate strategy, investment management, corporate advisory (including equity capital markets) and legal governance issues to the Calix board. Mr Dixon is currently Chief Strategy Officer for HPX. Mr Dixons investment banking and legal experience includes private legal practice experience at Mallesons Stephen Jacques in Sydney and Linklaters in London, as well as over nine years executive experience as an investment banker.
|
| Mr Darren Charles | Chief Financial OfficerCompany Secretary |
-
|
|
| Darren Charles | Chief Financial OfficerCompany Secretary |
-
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| J P Morgan Nominees Australia Pty Limited | 43,179,876 | 20.10% |
| UBS Nominees Pty Ltd | 22,789,549 | 10.61% |
| Citicorp Nominees Pty Limited | 13,585,438 | 6.33% |
| HSBC Custody Nominees (Australia) Limited | 13,412,595 | 6.24% |
| Nicholas Merriman | 8,108,286 | 3.78% |
| Mr Paul Crowther | 5,389,438 | 2.51% |
| Dr Mark Geoffrey Sceats | 3,655,264 | 1.70% |
| Mark Geoffrey Sceats <Sceats Superannuation Fund> | 2,847,344 | 1.33% |
| Pigeons Super Pty Limited <The Hodgson Family S/F A/C> | 2,461,597 | 1.15% |
| BNP Paribas Nominees Pty Ltd <HUB24 Custodial Serv Ltd> | 2,325,844 | 1.08% |
| Phil Hodgson | 1,888,309 | 0.88% |
| J P Morgan Nominees Australia Pty Limited 1 | 1,799,141 | 0.84% |
| Mr Jacob Shields Ulrich | 1,703,133 | 0.79% |
| Warbont Nominees Pty Ltd <Unpaid Entrepot A/C> | 1,318,636 | 0.61% |
| Jeneil Super Pty Ltd <Jeneil Super Fund A/C> | 1,266,388 | 0.59% |
| Mr John Andrew Hamilton | 1,223,639 | 0.57% |
| Mr Timothy John Reed & Ms Karola Brent <The Private Fund S/F A/C> | 1,169,000 | 0.54% |
| Cy Capital Pty Ltd | 1,135,000 | 0.53% |
| BNP Paribas Noms Pty Ltd | 1,106,402 | 0.52% |
| Turnbull Super Fund Pty Ltd <The Turnbull Super Fund A/C> | 1,057,719 | 0.48% |
